PortfoliosLab logoPortfoliosLab logo
CLBT vs. ABSI
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

CLBT vs. ABSI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cellebrite DI Ltd. (CLBT) and Absci Corporation (ABSI). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CLBT vs. ABSI - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CLBT
Cellebrite DI Ltd.
-23.57%-18.16%154.39%98.62%-45.64%-21.76%
ABSI
Absci Corporation
-14.04%33.21%-37.62%100.00%-74.39%-56.34%

Fundamentals

Market Cap

CLBT:

$3.47B

ABSI:

$451.83M

EPS

CLBT:

$0.31

ABSI:

-$0.82

PS Ratio

CLBT:

7.24

ABSI:

150.70

PB Ratio

CLBT:

7.16

ABSI:

2.38

Total Revenue (TTM)

CLBT:

$475.68M

ABSI:

$2.80M

Gross Profit (TTM)

CLBT:

$400.50M

ABSI:

-$36.85M

EBITDA (TTM)

CLBT:

$83.65M

ABSI:

-$112.98M

Returns By Period

In the year-to-date period, CLBT achieves a -23.57% return, which is significantly lower than ABSI's -14.04% return.


CLBT

1D
4.16%
1M
3.30%
YTD
-23.57%
6M
-25.63%
1Y
-29.08%
3Y*
31.28%
5Y*
10Y*

ABSI

1D
8.70%
1M
9.49%
YTD
-14.04%
6M
-1.32%
1Y
19.52%
3Y*
19.68%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLBT vs. ABSI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLBT
CLBT Risk / Return Rank: 1515
Overall Rank
CLBT Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
CLBT Sortino Ratio Rank: 1515
Sortino Ratio Rank
CLBT Omega Ratio Rank: 1717
Omega Ratio Rank
CLBT Calmar Ratio Rank: 1717
Calmar Ratio Rank
CLBT Martin Ratio Rank: 1111
Martin Ratio Rank

ABSI
ABSI Risk / Return Rank: 5151
Overall Rank
ABSI Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
ABSI Sortino Ratio Rank: 5757
Sortino Ratio Rank
ABSI Omega Ratio Rank: 5353
Omega Ratio Rank
ABSI Calmar Ratio Rank: 4848
Calmar Ratio Rank
ABSI Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLBT vs. ABSI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cellebrite DI Ltd. (CLBT) and Absci Corporation (ABSI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLBTABSIDifference

Sharpe ratio

Return per unit of total volatility

-0.62

0.22

-0.84

Sortino ratio

Return per unit of downside risk

-0.75

1.01

-1.76

Omega ratio

Gain probability vs. loss probability

0.91

1.12

-0.21

Calmar ratio

Return relative to maximum drawdown

-0.72

0.21

-0.92

Martin ratio

Return relative to average drawdown

-1.48

0.39

-1.87

CLBT vs. ABSI - Sharpe Ratio Comparison

The current CLBT Sharpe Ratio is -0.62, which is lower than the ABSI Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of CLBT and ABSI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


CLBTABSIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.62

0.22

-0.84

Sharpe Ratio (All Time)

Calculated using the full available price history

0.14

-0.36

+0.49

Correlation

The correlation between CLBT and ABSI is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

CLBT vs. ABSI - Dividend Comparison

Neither CLBT nor ABSI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CLBT vs. ABSI - Drawdown Comparison

The maximum CLBT drawdown since its inception was -67.74%, smaller than the maximum ABSI drawdown of -96.20%. Use the drawdown chart below to compare losses from any high point for CLBT and ABSI.


Loading graphics...

Drawdown Indicators


CLBTABSIDifference

Max Drawdown

Largest peak-to-trough decline

-67.74%

-96.20%

+28.46%

Max Drawdown (1Y)

Largest decline over 1 year

-40.71%

-54.00%

+13.29%

Current Drawdown

Current decline from peak

-47.00%

-90.10%

+43.10%

Average Drawdown

Average peak-to-trough decline

-33.92%

-84.81%

+50.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.69%

28.35%

-8.66%

Volatility

CLBT vs. ABSI - Volatility Comparison

The current volatility for Cellebrite DI Ltd. (CLBT) is 14.41%, while Absci Corporation (ABSI) has a volatility of 29.96%. This indicates that CLBT experiences smaller price fluctuations and is considered to be less risky than ABSI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


CLBTABSIDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.41%

29.96%

-15.55%

Volatility (6M)

Calculated over the trailing 6-month period

37.54%

70.05%

-32.51%

Volatility (1Y)

Calculated over the trailing 1-year period

47.01%

89.36%

-42.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

49.58%

96.13%

-46.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.58%

96.13%

-46.55%

Financials

CLBT vs. ABSI - Financials Comparison

This section allows you to compare key financial metrics between Cellebrite DI Ltd. and Absci Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
128.82M
650.00K
(CLBT) Total Revenue
(ABSI) Total Revenue
Values in USD except per share items